查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413850

人工授精市场 - 2024-2030 年全球预测

Artificial Insemination Market - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年人工授精市场规模为31.7亿美元，预计2024年将达34.2亿美元，2030年将达54.9亿美元，复合年增长率为8.16%。

世界人工授精市场

主要市场统计
基准年[2023] 31.7亿美元
预测年份 [2024] 34.2亿美元
预测年份 [2030] 54.9亿美元
复合年增长率（%） 8.16%
人工授精市场-IMG1

人工授精是指将精子直接输送到女性生殖道的不孕症治疗方法。这项技术涉及一种医疗程序，透过人工方式而不是透过自然交配将来自伴侣或捐赠者的精子插入女性的子宫颈、子宫腔或输卵管。近年来，与无精子症或精子数量极少有关的几种男性不孕问题以及与 Y 染色体有关的遗传性疾病的患病率有所增加，导致需要人工授精来帮助受孕。发生。此外，随着中产阶级人口的不断增长，新兴经济体不孕症服务的扩展也扩大了人工授精技术的范围和应用。然而，人工授精程序的复杂性和成功率低，再加上熟练人员的缺乏，阻碍了该行业的发展。此外，与人工授精相关的一些伦理和安全问题引起了人们对该技术的可靠性和可接受性的担忧。然而，家庭人工授精和不孕症治疗套件的核准标誌着人工授精市场的有利法规环境，有助于抵消道德和安全限制方面的挑战。领先企业也正在探索开发排卵预测的非侵入性方法来优化人工授精时机，以及融合人工智慧技术对人工授精成功率进行预测分析。

区域洞察

美洲，特别是美国和加拿大，拥有强大的医疗基础设施，包括多种不孕症治疗服务报销系统。此外，不断变化的社会文化趋势，例如对维持生殖健康重要性的认识、对人工授精服务可用性的认识以及晚婚，进一步增加了对生殖技术的需求。欧盟国家对人工授精的需求和行为有不同程度的特点，其中许多受到当地法规和文化态度的影响。一些欧盟国家处于生殖研究投资的前沿，也支持了市场扩张。在亚太地区，印度、中国和日本等国家提供政府支援政策，以促进人工授精技术的采用。在中国，由于不孕率上升和一胎政策的放宽，人工授精的需求正在迅速扩大。

FPNV定位矩阵

FPNV定位矩阵对于评估人工授精市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对人工授精市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-人工授精市场的市场规模与预测是多少？

2-人工授精市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-人工授精市场的技术趋势和法律规范是什么？

4-人工授精市场主要供应商的市场占有率为何？

5-进入人工授精市场合适的型态和策略手段有哪些？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球男性生育问题和受孕困难的盛行率不断上升
      • 在世界各地扩大生育诊所和医院
      • 政府努力改善生殖健康并扩大人工授精的机会
    • 抑制因素
      • 进行人工授精的复杂性和缺乏熟练人员
    • 机会
      • 提高人工授精程序准确性和成功率的进展
      • 核准家庭不孕症套件和新的人工授精解决方案
    • 任务
      • 与人工授精相关的伦理问题与安全问题
  • 市场区隔分析
    • 产品：人们越来越偏好能够提供更大舒适度和便利性的居家概念设备
    • 捐赠者类型：改善冷冻捐赠者精液储存条件和保存的进展
    • 技术：持续研究以提高宫内授精成功率
    • 服务供应商：IVF中心提供广泛的生育服务和患者照护的能力
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章美洲人工授精市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第七章亚太地区人工授精市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第八章欧洲、中东和非洲人工授精市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第9章 竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析
    • 奖项/奖励/扩展

第10章竞争产品组合

  • 主要公司简介
    • Conceivex Inc.
    • Femasys Inc.
    • Fujifilm Irvine Scientific
    • Hamilton Thorne
    • IMV Technologies
    • INVO Bioscience
    • Mosie Baby
    • Pride Angel
    • Rinovum Women's Health Company
    • Vitrolife AB
  • 主要产品系列

第十一章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-A37FCEE1175B

[187 Pages Report] The Artificial Insemination Market size was estimated at USD 3.17 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 8.16% to reach USD 5.49 billion by 2030.

Global Artificial Insemination Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.17 billion
Estimated Year [2024] USD 3.42 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 8.16%
Artificial Insemination Market - IMG1

Artificial insemination refers to a fertility treatment method used to deliver sperm directly into the female reproductive tract. This technique involves a medical procedure where sperm, either from a partner or donor, is inserted into a woman's cervix, uterine cavity, or fallopian tubes using artificial means rather than by natural copulation. In recent years, several male infertility issues related to azoospermia or very low sperm count and the prevalence of inherited genetic diseases linked to the Y-chromosome are increasing, creating the need for artificial insemination to help conceive. Additionally, the expansion of fertility services in emerging economies with growing middle-class populations has also extended the scope and application of artificial insemination technologies. However, procedural complexities and the low success rate of artificial insemination, coupled with a lack of skilled personnel, impede the growth of the industry. Additionally, several ethical and safety issues related to artificial insemination raise concerns about the reliability and acceptability of the technology. However, approvals for at-home artificial insemination and fertility kits signal a positive regulatory environment for the artificial insemination market, thereby helping offset challenges related to ethical and safety constraints. Key players are also exploring the development of non-invasive methods for ovulation prediction to optimize timing for artificial insemination and the integration of artificial intelligence techniques for predictive analytics of the success rate of artificial insemination.

Regional Insights

The Americas region, particularly the US and Canada, boasts of a robust healthcare infrastructure, with several reimbursement plans for fertility services. Additionally, recognition of the importance of maintaining reproductive health, awareness about the availability of artificial insemination services, and evolving socio-cultural trends, such as the tendency to have children later in life, have further cemented the need for reproductive technologies. EU countries are characterized by varying degrees of need and behavior around artificial insemination, largely influenced by local regulations and cultural attitudes. Several EU nations are at the forefront of investing in reproductive research, which also supports the market expansion. In APAC, nations such as India, China, and Japan provide supportive government policies to promote the adoption of artificial insemination technologies. China's need for artificial insemination has rapidly expanded due to increasing infertility rates and the relaxation of the one-child policy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Insemination Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Insemination Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Insemination Market, highlighting leading vendors and their innovative profiles. These include Conceivex Inc., Femasys Inc., Fujifilm Irvine Scientific, Hamilton Thorne, IMV Technologies, INVO Bioscience, Mosie Baby, Pride Angel, Rinovum Women's Health Company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Artificial Insemination Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Insemination Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Insemination Market?

3. What are the technology trends and regulatory frameworks in the Artificial Insemination Market?

4. What is the market share of the leading vendors in the Artificial Insemination Market?

5. Which modes and strategic moves are suitable for entering the Artificial Insemination Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Insemination Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of male fertility issues across the world and difficulties in conceiving
      • 5.1.1.2. Expansion of fertility clinics and hospitals across the world
      • 5.1.1.3. Government initiatives to improve reproductive health and expand access to artificial insemination
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in conducting artificial insemination and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements to improve the accuracy and success rate of artificial insemination procedures
      • 5.1.3.2. Approvals for at-home fertility kits and novel artificial insemination solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and safety concerns related to artificial insemination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for home conception devices to achieve higher comfort and convenience
    • 5.2.2. Donor Type: Advancements to improve storage conditions and preservation of frozen donor semen
    • 5.2.3. Technique: Ongoing research initiatives to improve the success of intrauterine insemination
    • 5.2.4. Service Provider: Ability of IVF centers to provide a plethora of fertility services and patient care
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Americas Artificial Insemination Market

  • 6.1. Introduction
  • 6.2. Argentina
  • 6.3. Brazil
  • 6.4. Canada
  • 6.5. Mexico
  • 6.6. United States

7. Asia-Pacific Artificial Insemination Market

  • 7.1. Introduction
  • 7.2. Australia
  • 7.3. China
  • 7.4. India
  • 7.5. Indonesia
  • 7.6. Japan
  • 7.7. Malaysia
  • 7.8. Philippines
  • 7.9. Singapore
  • 7.10. South Korea
  • 7.11. Taiwan
  • 7.12. Thailand
  • 7.13. Vietnam

8. Europe, Middle East & Africa Artificial Insemination Market

  • 8.1. Introduction
  • 8.2. Denmark
  • 8.3. Egypt
  • 8.4. Finland
  • 8.5. France
  • 8.6. Germany
  • 8.7. Israel
  • 8.8. Italy
  • 8.9. Netherlands
  • 8.10. Nigeria
  • 8.11. Norway
  • 8.12. Poland
  • 8.13. Qatar
  • 8.14. Russia
  • 8.15. Saudi Arabia
  • 8.16. South Africa
  • 8.17. Spain
  • 8.18. Sweden
  • 8.19. Switzerland
  • 8.20. Turkey
  • 8.21. United Arab Emirates
  • 8.22. United Kingdom

9. Competitive Landscape

  • 9.1. FPNV Positioning Matrix
  • 9.2. Market Share Analysis, By Key Player
  • 9.3. Competitive Scenario Analysis, By Key Player
    • 9.3.1. Award, Recognition, & Expansion
      • 9.3.1.1. Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit
      • 9.3.1.2. Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution

10. Competitive Portfolio

  • 10.1. Key Company Profiles
    • 10.1.1. Conceivex Inc.
    • 10.1.2. Femasys Inc.
    • 10.1.3. Fujifilm Irvine Scientific
    • 10.1.4. Hamilton Thorne
    • 10.1.5. IMV Technologies
    • 10.1.6. INVO Bioscience
    • 10.1.7. Mosie Baby
    • 10.1.8. Pride Angel
    • 10.1.9. Rinovum Women's Health Company
    • 10.1.10. Vitrolife AB
  • 10.2. Key Product Portfolio

11. Appendix

  • 11.1. Discussion Guide
  • 11.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INSEMINATION MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INSEMINATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INSEMINATION MARKET DYNAMICS
  • FIGURE 7. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 8. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 10. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 16. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INSEMINATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 7. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 10. ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 11. ARTIFICIAL INSEMINATION MARKET LICENSE & PRICING